Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study

N Tripolt; P Pferschy; E Kolesnik; N Verheyen; K Ablasser; S Sailer; J Breitegger; H Alber; R Berger; K Leitner; Michael Lichtenauer; D Mortl; A Oulhaj; C Reiter; T Rieder; C Saly; J Siller-Matula; F Weidinger; P Zechner; D Von Lewinski; H Sourij

Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study

N Tripolt, P Pferschy, E Kolesnik, N Verheyen, K Ablasser, S Sailer, J Breitegger, H Alber, R Berger, K Leitner, Michael Lichtenauer, D Mortl, A Oulhaj, C Reiter, T Rieder, C Saly, J Siller-Matula, F Weidinger, P Zechner, D Von LewinskiH Sourij

Department of Internal Medicine II - Division of Cardiology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	German
Pages (from-to)	S345-S345
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	132
Publication status	Published - 2020

Cite this

Tripolt, N., Pferschy, P., Kolesnik, E., Verheyen, N., Ablasser, K., Sailer, S., Breitegger, J., Alber, H., Berger, R., Leitner, K., Lichtenauer, M., Mortl, D., Oulhaj, A., Reiter, C., Rieder, T., Saly, C., Siller-Matula, J., Weidinger, F., Zechner, P., ... Sourij, H. (2020). Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study. WIENER KLINISCHE WOCHENSCHRIFT, 132, S345-S345.

@article{a4bb2bb3d7ea467a83876304c41c191d,

title = "Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study",

author = "N Tripolt and P Pferschy and E Kolesnik and N Verheyen and K Ablasser and S Sailer and J Breitegger and H Alber and R Berger and K Leitner and Michael Lichtenauer and D Mortl and A Oulhaj and C Reiter and T Rieder and C Saly and J Siller-Matula and F Weidinger and P Zechner and {Von Lewinski}, D and H Sourij",

year = "2020",

language = "Deutsch",

volume = "132",

pages = "S345--S345",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

}

Tripolt, N, Pferschy, P, Kolesnik, E, Verheyen, N, Ablasser, K, Sailer, S, Breitegger, J, Alber, H, Berger, R, Leitner, K, Lichtenauer, M, Mortl, D, Oulhaj, A, Reiter, C, Rieder, T, Saly, C, Siller-Matula, J, Weidinger, F, Zechner, P, Von Lewinski, D & Sourij, H 2020, 'Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study', WIENER KLINISCHE WOCHENSCHRIFT, vol. 132, pp. S345-S345.

TY - JOUR

T1 - Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study

AU - Tripolt, N

AU - Pferschy, P

AU - Kolesnik, E

AU - Verheyen, N

AU - Ablasser, K

AU - Sailer, S

AU - Breitegger, J

AU - Alber, H

AU - Berger, R

AU - Leitner, K

AU - Lichtenauer, Michael

AU - Mortl, D

AU - Oulhaj, A

AU - Reiter, C

AU - Rieder, T

AU - Saly, C

AU - Siller-Matula, J

AU - Weidinger, F

AU - Zechner, P

AU - Von Lewinski, D

AU - Sourij, H

PY - 2020

Y1 - 2020

M3 - Abstrakt (Zeitschrift)

SN - 0043-5325

VL - 132

SP - S345-S345

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

ER -